VERU

Veru (VERU)

About Veru (VERU)

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.

Details

Daily high

$2.37

Daily low

$2.21

Price at open

$2.24

52 Week High

$7.40

52 Week Low

$2.10

Market cap

36.0M

Dividend yield

0.00%

Volume

65,874

Avg. volume

139,266

P/E ratio

-1.76

Veru News